Low clinical conversion rate in clinically isolated syndrome patients – diagnostic benefit of McDonald 2010 criteria?-Reference-Cited by-同舟云学术

Low clinical conversion rate in clinically isolated syndrome patients – diagnostic benefit of McDonald 2010 criteria?

Published:2017-12-02 Issue:2 Volume:25 Page:247
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Rosenkranz S. C.¹²^ORCID,Kaulen B.¹²,Neuhaus A.³,Siemonsen S.⁴,Köpke S.⁵,Daumer M.³,Stellmann J.‐P.¹²^ORCID,Heesen C.¹²^ORCID

Affiliation:

1. Institut für Neuroimmunologie und Multiple Sklerose Zentrum für Molekulare NeurobiologieUniversity Medical Center Hamburg‐Eppendorf Hamburg Germany

2. Department of Neurology University Medical Center Hamburg‐Eppendorf HamburgGermany

3. Sylvia Lawry Centre for Multiple Sclerosis Research MünchenGermany

4. Department of Diagnostic and Interventional Neuroradiology University Medical Center Hamburg‐Eppendorf HamburgGermany

5. Institute for Social Medicine and Epidemiology University of Lübeck Lübeck Germany

Funder

Biogen

Merck

Seventh Framework Programme

Bundesministerium für Bildung und Forschung

Gemeinnützige Hertie-Stiftung

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.13476

Reference28 articles.

1. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

3. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

4. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

5. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines;Filippi M;Lancet Neurol,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study protocol for a randomised controlled trial of a web-based behavioural lifestyle programme for emPOWERment in early Multiple Sclerosis (POWER@MS1);BMJ Open;2021-02

2. Validity of the McDonald criteria in predicting second events in multiple sclerosis;Multiple Sclerosis and Related Disorders;2020-08

3. Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NMOSD);Sleep Medicine;2020-06

4. What do we currently know about the clinically isolated syndrome suggestive of multiple sclerosis? An update;Reviews in the Neurosciences;2020-04-28

5. Updated criteria for diagnosing Multiple Sclerosis;Advances in Clinical Neuroscience & Rehabilitation;2019